RIGEL PHARMACEUTICALS INC — Director's Dealing 2020

Feb 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2020-02-06

Reporting Person: RODRIGUEZ RAUL R (Director, CEO, President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-06	Stock Option (right to buy)	$2.42	A	650000	Acquired	2030-02-06	Common Stock (650000)	Direct

Footnotes

F1: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the issuer through each such period.